Search Results - "Boki, K A"

Refine Results
  1. 1

    Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis by TZELEPIS, G. E, KOKOSI, M, TZIOUFAS, A, TOYA, S. P, BOKI, K. A, ZORMPALA, A, MOUTSOPOULOS, H. M

    Published in The European respiratory journal (01-07-2010)
    “…We sought to determine the type of pulmonary involvement in microscopic polyangiitis (MPA), primarily focusing on pulmonary fibrosis (PF), its prevalence,…”
    Get full text
    Journal Article
  2. 2

    Lupus nephritis: treatment with mycophenolate mofetil by Kapitsinou, P. P., Boletis, J. N., Skopouli, F. N., Boki, K. A., Moutsopoulos, H. M.

    Published in Rheumatology (Oxford, England) (01-03-2004)
    “…Objective. To evaluate the safety and efficacy of mycophenolate mofetil (MMF) treatment in patients with lupus nephritis. Methods. Eighteen patients with…”
    Get full text
    Journal Article
  3. 3

    Is the heart affected in primary Sjogren's syndrome? An echocardiographic study by VASSILIOU, V. A, MOYSSAKIS, I, BOKI, K. A, MOUTSOPOULOS, H. M

    “…To evaluate whether patients with primary Sjögren's syndrome without overt cardiac disease have echocardiographic abnormalities and their relation with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy by Tzelepis, G E, Kalliakosta, G, Tzioufas, A G, Sfikakis, P P, Mandros, C, Boki, K A, Roussos, C, Moutsopoulos, H M

    Published in Annals of the rheumatic diseases (01-06-2009)
    “…To assess the relationship between thoracoabdominal motion during quiet breathing and standardised indices of disease severity in patients with ankylosing…”
    Get more information
    Journal Article
  6. 6

    Risk factors for central nervous system involvement in systemic lupus erythematosus by KARASSA, F.B., IOANNIDIS, J.P.A., TOULOUMI, G., BOKI, K.A., MOUTSOPOULOS, H.M.

    Published in QJM : An International Journal of Medicine (01-03-2000)
    “…We investigated risk factors for central nervous system (CNS) involvement in systemic lupus erythematosus (SLE), in 32 such patients individually matched 1 : 3…”
    Get full text
    Journal Article
  7. 7

    Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide by Ioannidis, John P.A., Boki, Kyriaki A., Katsorida, Maria E., Drosos, Alexandros A., Skopouli, Fotini N., Boletis, John N., Moutsopoulos, Haralampos M.

    Published in Kidney international (01-01-2000)
    “…Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Long-term intravenous cyclophosphamide (IVC) in…”
    Get full text
    Journal Article
  8. 8

    Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis by Boletis, John N, Ioannidis, John PA, Boki, Kyriaki A, Moutsopoulos, Haralampos M

    Published in The Lancet (British edition) (14-08-1999)
    “…Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard…”
    Get full text
    Journal Article
  9. 9

    Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome by Tektonidou, M.G., Ioannidis, J.P.A., Boki, K.A., Vlachoyiannopoulos, P.G., Moutsopoulos, H.M.

    Published in QJM : An International Journal of Medicine (01-08-2000)
    “…We assessed whether initial clinical presentations suggestive of antiphospholipid syndrome (APS) predicted the subsequent rate and type of serious clinical…”
    Get full text
    Journal Article
  10. 10

    Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome by Tektonidou, M G, Ioannidis, J P A, Moyssakis, I, Boki, K A, Vassiliou, V, Vlachoyiannopoulos, P G, Kyriakidis, M K, Moutsopoulos, H M

    Published in Annals of the rheumatic diseases (01-01-2001)
    “…OBJECTIVE To evaluate the prevalence of diastolic dysfunction in patients with anticardiolipin antibodies (aCL) and to examine whether the antiphospholipid…”
    Get full text
    Journal Article
  11. 11

    Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open Treatment by Cherouvim, E P, Zintzaras, E, Boki, K A, Moutsopoulos, H M, Manoussakis, M N

    Published in Journal of clinical rheumatology (01-08-2004)
    “…BACKGROUND:Infliximab at the dose of 5 mg/kg per infusion has been shown effective for the treatment of active spondyloarthropathies. It is not clear if the 5…”
    Get full text
    Journal Article
  12. 12

    How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study by BOKI, Kyriaki A, IOANNIDIS, John P. A, SEGAS, John V, MARAGKOUDAKIS, Pavlos V, PETROU, Dimitrios, ADAMOPOULOS, George K, MOUTSOPOULOS, Haralampos M

    Published in Journal of rheumatology (01-04-2001)
    “…We evaluated whether sensorineural loss and vestibular abnormalities are common in patients with primary Sjögren's syndrome (pSS) and whether such…”
    Get full text
    Conference Proceeding Journal Article
  13. 13

    Thrombotic thrombocytopenic purpura in adult Still's disease by Boki, K A, Tsirantonaki, M J, Markakis, K, Moutsopoulos, H M

    Published in Journal of rheumatology (01-02-1996)
    “…We describe 2 patients with adult Still's disease who developed thrombotic thrombocytopenic purpura (TTP) and were successfully treated. Although TTP has been…”
    Get more information
    Journal Article
  14. 14

    Pure red cell aplasia as presentation of systemic lupus erythematosus : Antibodies to erythropoietin by LINARDAKI, G. D, BOKI, K. A, FERTAKIS, A, TZIOUFAS, A. G

    “…In this case report we describe two patients with pure red cell aplasia (PRCA) as an initial manifestation of systemic lupus erythematosus (SLE). Antibodies to…”
    Get full text
    Conference Proceeding Journal Article
  15. 15

    Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients by Boki, K A, Drosos, A A, Tzioufas, A G, Lanchbury, J S, Panayi, G S, Moutsopoulos, H M

    Published in Annals of the rheumatic diseases (01-07-1993)
    “…OBJECTIVES--Previous reports have shown that HLA-DR4 may be a severity marker for rheumatoid arthritis (RA) in patients of northern European origin. The aim of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Polymyositis associated with primary biliary cirrhosis by Boki, K A, Dourakis, S P

    Published in Clinical rheumatology (01-05-1995)
    “…The coexistence of polymyositis (PM) and primary biliary cirrhosis (PBC) is rare; only nine cases have been described in English literature. We report a case…”
    Get full text
    Journal Article
  18. 18

    Mixed Cryoglobulinemia in Greece: Primary disorders in 10 cases by Boki, K. A., Linardaki, G. D., Galanopoulou, V., Vaiopoulos, G., Tzioufas, A. G., Moutsopoulos, H. M.

    “…Mixed cryoglobulinemia (MC) is a systemic disorder whose pathogenesis is based on the presence of serum cryoglobulins. The purpose of this study was to…”
    Get full text
    Journal Article
  19. 19

    Takayasu's arteritis-associated aneurysm formation without steno-occlusive lesions by Boki, K A, Pakas, J, Kekatou, K, Kataxaki, E, Papapavlou, E

    Published in Clinical rheumatology (01-01-2000)
    “…The authors report a case of a 20-year-old woman with Takayasu's arteritis (TA) presenting with recurrent erythema nodosum-like lesions, elevated acute-phase…”
    Get full text
    Journal Article
  20. 20

    Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study by Boki, K A, Kurki, P, Holthofer, H, Tzioufas, A G, Drosos, A A, Moutsopoulos, H M

    Published in Journal of rheumatology (01-11-1995)
    “…The presence of antikeratin antibodies (AKA) has been associated with rheumatoid arthritis (RA) in patients from north and central Europe. Our aim was to…”
    Get more information
    Journal Article